Bortezomib retreatment for relapsed and refractory multiple myeloma in real-world clinical practice.
Hulin C, de la Rubia J, Dimopoulos MA, Terpos E, Katodritou E, Hungria V, De Samblanx H, Stoppa AM, Aagesen J, Sargin D, Sioni A, Belch A, Diels J, Olie RA, Robinson D Jr, Potamianou A, van de Velde H, Delforge M.
Hulin C, et al. Among authors: terpos e.
Health Sci Rep. 2018 Dec 7;2(1):e104. doi: 10.1002/hsr2.104. eCollection 2019 Jan.
Health Sci Rep. 2018.
PMID: 30697597
Free PMC article.